Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIME: Diabetes Prevention in Caribbean-descent Individuals
NCT03258723Phase 4Terminated
- Sponsor
- Yale University
- Start
- Jul 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Yale University. Primary endpoint: Hemoglobin A1c at 12 months. Started Jul 2018; status: terminated.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03258723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03258723.